New User? Sign Up | Sign In

Insider Trading - GLAXOSMITHKLINE PLC

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Trading Transactions for GLAXOSMITHKLINE PLC

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2016-03-14
Purchase(M)
2016-03-15
4:31 pm
Theravance Biopharma Inc. TBPH GLAXOSMITHKLINE PLC
10% Owner
1,301,015 $17.7 $23,027,966 9,644,807
(Indirect)
View
2016-10-24
Purchase
2016-10-26
5:49 pm
CRISPR Therapeutics AG CRSP GLAXOSMITHKLINE PLC
10% Owner
66,500 $14 $931,000 3,220,627
(Indirect)
View
2017-03-27
Sale
2017-03-29
4:04 pm
HTG MOLECULAR DIAGNOSTICS INC HTGM GLAXOSMITHKLINE PLC
Former 10% Owner
300,000 $10.15 $3,045,180 792,781
(Indirect)
View
2017-03-27
Sale(A)
2017-03-30
4:11 pm
HTG MOLECULAR DIAGNOSTICS INC HTGM GLAXOSMITHKLINE PLC
Former 10% Owner
300,000 $10.15 $3,045,180 792,781
(Indirect)
View
2017-11-06
Purchase
2017-11-07
7:42 pm
Spero Therapeutics Inc. SPRO GLAXOSMITHKLINE PLC
10% Owner
428,571 $14 $5,999,994 1,854,006
(Indirect)
View
2018-07-02
Purchase
2018-07-03
5:59 pm
Translate Bio Inc. TBIO GLAXOSMITHKLINE PLC
10% Owner
269,230 $13 $3,499,990 3,697,912
(Indirect)
View
2018-07-17
Purchase
2018-07-17
5:01 pm
Spero Therapeutics Inc. SPRO GLAXOSMITHKLINE PLC
10% Owner
80,000 $12.5 $1,000,000 1,934,006
(Indirect)
View
2018-07-30
Purchase
2018-08-01
6:32 pm
Liquidia Technologies Inc LQDA GLAXOSMITHKLINE PLC
Former 10% holder
148,818 $11 $1,636,998 624,422
(Indirect)
View
2018-09-18
Purchase
2018-09-20
5:18 pm
Principia Biopharma Inc. PRNB GLAXOSMITHKLINE PLC
10% Owner
270,000 $17 $4,590,000 2,625,713
(Indirect)
View
2018-10-16
Sale
2018-10-18
5:03 pm
ChemoCentryx Inc. CCXI GLAXOSMITHKLINE PLC
Former 10% holder
7,343,492 $11.69 $85,845,418 0
(Indirect)
View
2019-04-22
Purchase
2019-04-24
7:28 pm
Turning Point Therapeutics Inc. TPTX GLAXOSMITHKLINE PLC
Director
10% Owner
325,000 $18 $5,850,000 1,992,550
(Indirect)
View
2019-05-28
Purchase
2019-05-30
5:47 pm
BICYCLE THERAPEUTICS plc BCYC GLAXOSMITHKLINE PLC
Director
10% Owner
385,714 $14 $5,399,996 1,915,275
(Indirect)
View
2019-06-24
Purchase
2019-06-26
10:46 am
GENOCEA BIOSCIENCES Inc GNCA GLAXOSMITHKLINE PLC
10% Owner
1,857,142 $3.5 $6,499,997 3,365,884
(Indirect)
View
2019-07-01
Purchase
2019-07-02
4:13 pm
Morphic Holding Inc. MORF GLAXOSMITHKLINE PLC
Director
333,333 $15 $4,999,995 2,633,772
(Indirect)
View
2019-09-10
Purchase
2019-09-12
4:18 pm
Turning Point Therapeutics Inc. TPTX GLAXOSMITHKLINE PLC
Director
177,777 $45 $7,999,965 2,170,327
(Indirect)
View
2019-10-18
Purchase
2019-10-22
5:36 pm
Principia Biopharma Inc. PRNB GLAXOSMITHKLINE PLC
Former 10% Owner
357,142 $28 $9,999,976 2,982,855
(Indirect)
View
2020-05-20
Sale
2020-05-21
5:21 pm
Progyny Inc. PGNY GLAXOSMITHKLINE PLC
10% Owner
4,000,000 $25.75 $103,000,000 6,238,244
(Indirect)
View
2020-05-21
Purchase
2020-05-26
4:17 pm
Turning Point Therapeutics Inc. TPTX GLAXOSMITHKLINE PLC
Director
83,333 $60 $4,999,980 2,253,660
(Indirect)
View
2020-07-14
Purchase
2020-07-16
8:13 pm
Nkarta Inc. NKTX GLAXOSMITHKLINE PLC
Director
10% Owner
833,333 $18 $14,999,994 3,150,732
(Indirect)
View
2020-07-17
Purchase
2020-07-22
4:18 pm
Pandion Therapeutics Inc. PAND GLAXOSMITHKLINE PLC
Director
10% Owner
361,111 $18 $6,499,998 2,248,304
(Indirect)
View
2020-07-24
Purchase
2020-07-30
8:56 pm
GENOCEA BIOSCIENCES Inc GNCA GLAXOSMITHKLINE PLC
10% Owner
1,260,504 $2.25 $2,836,134 4,626,389
(Indirect)
View
2020-07-14
Sale
2020-09-18
12:04 pm
BICYCLE THERAPEUTICS plc BCYC GLAXOSMITHKLINE PLC
10% Owner
4,744 $19.36 $91,826 1,910,531
(Indirect)
View
(A) Indicate amendment filing.
(M) Indicate average unit share price adjusted based on the original filings.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2016-10-18
Option Award
2016-10-20
5:47 pm
N/A
2026-10-18
CRISPR Therapeutics AG CRSP GLAXOSMITHKLINE PLC
10% Owner
30,000 $14 30,000
(Indirect)
View
2016-10-24
Conversion
2016-10-26
5:49 pm
N/A
N/A
CRISPR Therapeutics AG CRSP GLAXOSMITHKLINE PLC
10% Owner
2,942,560 $0 3,220,627
(Indirect)
View
2016-10-24
Conversion
2016-10-26
5:49 pm
N/A
N/A
CRISPR Therapeutics AG CRSP GLAXOSMITHKLINE PLC
10% Owner
211,567 $0 3,220,627
(Indirect)
View
2016-10-24
Conversion
2016-10-26
5:49 pm
N/A
N/A
CRISPR Therapeutics AG CRSP GLAXOSMITHKLINE PLC
10% Owner
2,942,560 $0 3,220,627
(Indirect)
View
2016-10-24
Conversion
2016-10-26
5:49 pm
N/A
N/A
CRISPR Therapeutics AG CRSP GLAXOSMITHKLINE PLC
10% Owner
211,567 $0 3,220,627
(Indirect)
View
2017-11-06
Conversion
2017-11-07
7:42 pm
N/A
N/A
Spero Therapeutics Inc. SPRO GLAXOSMITHKLINE PLC
10% Owner
244,147 $0 1,854,006
(Indirect)
View
2017-11-06
Conversion
2017-11-07
7:42 pm
N/A
N/A
Spero Therapeutics Inc. SPRO GLAXOSMITHKLINE PLC
10% Owner
246,272 $0 1,854,006
(Indirect)
View
2017-11-06
Conversion
2017-11-07
7:42 pm
N/A
N/A
Spero Therapeutics Inc. SPRO GLAXOSMITHKLINE PLC
10% Owner
328,992 $0 1,854,006
(Indirect)
View
2017-11-06
Conversion
2017-11-07
7:42 pm
N/A
N/A
Spero Therapeutics Inc. SPRO GLAXOSMITHKLINE PLC
10% Owner
606,024 $0 1,854,006
(Indirect)
View
2017-11-06
Conversion
2017-11-07
7:42 pm
N/A
N/A
Spero Therapeutics Inc. SPRO GLAXOSMITHKLINE PLC
10% Owner
1,483,784 $0 1,854,006
(Indirect)
View
2017-11-06
Conversion
2017-11-07
7:42 pm
N/A
N/A
Spero Therapeutics Inc. SPRO GLAXOSMITHKLINE PLC
10% Owner
982,906 $0 1,854,006
(Indirect)
View
2017-11-06
Conversion
2017-11-07
7:42 pm
N/A
N/A
Spero Therapeutics Inc. SPRO GLAXOSMITHKLINE PLC
10% Owner
1,250,000 $0 1,854,006
(Indirect)
View
2017-11-06
Conversion
2017-11-07
7:42 pm
N/A
N/A
Spero Therapeutics Inc. SPRO GLAXOSMITHKLINE PLC
10% Owner
3,683,045 $0 1,854,006
(Indirect)
View
2018-07-02
Conversion
2018-07-03
5:59 pm
N/A
N/A
Translate Bio Inc. TBIO GLAXOSMITHKLINE PLC
10% Owner
1,674,016 $0 3,697,912
(Indirect)
View
2018-07-02
Conversion
2018-07-03
5:59 pm
N/A
N/A
Translate Bio Inc. TBIO GLAXOSMITHKLINE PLC
10% Owner
1,300,116 $0 3,697,912
(Indirect)
View
2018-07-02
Conversion
2018-07-03
5:59 pm
N/A
N/A
Translate Bio Inc. TBIO GLAXOSMITHKLINE PLC
10% Owner
454,550 $0 3,697,912
(Indirect)
View
2018-07-02
Conversion
2018-07-03
5:59 pm
N/A
N/A
Translate Bio Inc. TBIO GLAXOSMITHKLINE PLC
10% Owner
9,300,000 $0 3,697,912
(Indirect)
View
2018-07-02
Conversion
2018-07-03
5:59 pm
N/A
N/A
Translate Bio Inc. TBIO GLAXOSMITHKLINE PLC
10% Owner
7,222,797 $0 3,697,912
(Indirect)
View
2018-07-02
Conversion
2018-07-03
5:59 pm
N/A
N/A
Translate Bio Inc. TBIO GLAXOSMITHKLINE PLC
10% Owner
2,525,253 $0 3,697,912
(Indirect)
View
2018-07-30
Conversion
2018-08-01
6:32 pm
N/A
N/A
Liquidia Technologies Inc LQDA GLAXOSMITHKLINE PLC
Former 10% holder
336,541 $0 624,422
(Indirect)
View
2018-07-30
Conversion
2018-08-01
6:32 pm
N/A
N/A
Liquidia Technologies Inc LQDA GLAXOSMITHKLINE PLC
Former 10% holder
118,570 $0 624,422
(Indirect)
View
2018-07-30
Conversion
2018-08-01
6:32 pm
N/A
N/A
Liquidia Technologies Inc LQDA GLAXOSMITHKLINE PLC
Former 10% holder
4,765,248 $0 624,422
(Indirect)
View
2018-07-30
Conversion
2018-08-01
6:32 pm
N/A
N/A
Liquidia Technologies Inc LQDA GLAXOSMITHKLINE PLC
Former 10% holder
344,853 $0 624,422
(Indirect)
View
2018-09-18
Conversion
2018-09-20
5:18 pm
N/A
N/A
Principia Biopharma Inc. PRNB GLAXOSMITHKLINE PLC
10% Owner
1,070,771 $0 2,625,713
(Indirect)
View
2018-09-18
Conversion
2018-09-20
5:18 pm
N/A
N/A
Principia Biopharma Inc. PRNB GLAXOSMITHKLINE PLC
10% Owner
312,741 $0 2,625,713
(Indirect)
View
2018-09-18
Conversion
2018-09-20
5:18 pm
N/A
N/A
Principia Biopharma Inc. PRNB GLAXOSMITHKLINE PLC
10% Owner
260,617 $0 2,625,713
(Indirect)
View
2018-09-18
Conversion
2018-09-20
5:18 pm
N/A
N/A
Principia Biopharma Inc. PRNB GLAXOSMITHKLINE PLC
10% Owner
544,047 $0 2,625,713
(Indirect)
View
2018-09-18
Conversion
2018-09-20
5:18 pm
N/A
N/A
Principia Biopharma Inc. PRNB GLAXOSMITHKLINE PLC
10% Owner
167,537 $0 2,625,713
(Indirect)
View
2018-09-18
Conversion
2018-09-20
5:18 pm
N/A
N/A
Principia Biopharma Inc. PRNB GLAXOSMITHKLINE PLC
10% Owner
9,726,783 $0 2,625,713
(Indirect)
View
2018-09-18
Conversion
2018-09-20
5:18 pm
N/A
N/A
Principia Biopharma Inc. PRNB GLAXOSMITHKLINE PLC
10% Owner
2,840,909 $0 2,625,713
(Indirect)
View
2018-09-18
Conversion
2018-09-20
5:18 pm
N/A
N/A
Principia Biopharma Inc. PRNB GLAXOSMITHKLINE PLC
10% Owner
2,367,424 $0 2,625,713
(Indirect)
View
2018-09-18
Conversion
2018-09-20
5:18 pm
N/A
N/A
Principia Biopharma Inc. PRNB GLAXOSMITHKLINE PLC
10% Owner
4,942,070 $0 2,625,713
(Indirect)
View
2018-09-18
Conversion
2018-09-20
5:18 pm
N/A
N/A
Principia Biopharma Inc. PRNB GLAXOSMITHKLINE PLC
10% Owner
1,521,895 $0 2,625,713
(Indirect)
View
2018-09-13
Option Award
2019-01-15
4:57 pm
N/A
2028-09-12
Principia Biopharma Inc. PRNB GLAXOSMITHKLINE PLC
10% Owner
20,475 $17 20,475
(Indirect)
View
2019-04-22
Conversion
2019-04-24
7:28 pm
N/A
N/A
Turning Point Therapeutics Inc. TPTX GLAXOSMITHKLINE PLC
Director
10% Owner
1,120,730 $0 1,992,550
(Indirect)
View
2019-04-22
Conversion
2019-04-24
7:28 pm
N/A
N/A
Turning Point Therapeutics Inc. TPTX GLAXOSMITHKLINE PLC
Director
10% Owner
546,820 $0 1,992,550
(Indirect)
View
2019-04-22
Conversion
2019-04-24
7:28 pm
N/A
N/A
Turning Point Therapeutics Inc. TPTX GLAXOSMITHKLINE PLC
Director
10% Owner
4,314,809 $0 1,992,550
(Indirect)
View
2019-04-22
Conversion
2019-04-24
7:28 pm
N/A
N/A
Turning Point Therapeutics Inc. TPTX GLAXOSMITHKLINE PLC
Director
10% Owner
2,105,259 $0 1,992,550
(Indirect)
View
2019-04-22
Option Award
2019-04-24
7:28 pm
N/A
2029-04-22
Turning Point Therapeutics Inc. TPTX GLAXOSMITHKLINE PLC
Director
10% Owner
15,000 $27.06 1,992,550
(Indirect)
View
2019-05-28
Conversion
2019-05-30
5:47 pm
N/A
N/A
BICYCLE THERAPEUTICS plc BCYC GLAXOSMITHKLINE PLC
Director
10% Owner
893,195 $0 1,915,275
(Indirect)
View
2019-05-28
Conversion
2019-05-30
5:47 pm
N/A
N/A
BICYCLE THERAPEUTICS plc BCYC GLAXOSMITHKLINE PLC
Director
10% Owner
636,366 $0 1,915,275
(Indirect)
View
2019-05-28
Conversion
2019-05-30
5:47 pm
N/A
N/A
BICYCLE THERAPEUTICS plc BCYC GLAXOSMITHKLINE PLC
Director
10% Owner
625,049 $0 1,915,275
(Indirect)
View
2019-05-28
Conversion
2019-05-30
5:47 pm
N/A
N/A
BICYCLE THERAPEUTICS plc BCYC GLAXOSMITHKLINE PLC
Director
10% Owner
445,323 $0 1,915,275
(Indirect)
View
2019-06-11
Option Award
2019-06-17
2:57 pm
N/A
2029-06-10
Principia Biopharma Inc. PRNB GLAXOSMITHKLINE PLC
10% Owner
10,240 $31.77 10,240
(Indirect)
View
2019-07-01
Conversion
2019-07-02
4:13 pm
N/A
N/A
Morphic Holding Inc. MORF GLAXOSMITHKLINE PLC
Director
1,469,950 $0 2,633,772
(Indirect)
View
2019-07-01
Conversion
2019-07-02
4:13 pm
N/A
N/A
Morphic Holding Inc. MORF GLAXOSMITHKLINE PLC
Director
830,489 $0 2,633,772
(Indirect)
View
2019-07-01
Conversion
2019-07-02
4:13 pm
N/A
N/A
Morphic Holding Inc. MORF GLAXOSMITHKLINE PLC
Director
1,469,950 $0 2,633,772
(Indirect)
View
2019-07-01
Conversion
2019-07-02
4:13 pm
N/A
N/A
Morphic Holding Inc. MORF GLAXOSMITHKLINE PLC
Director
830,489 $0 2,633,772
(Indirect)
View
2019-07-22
Conversion
2019-07-24
4:01 pm
N/A
N/A
Fulcrum Therapeutics Inc. FULC GLAXOSMITHKLINE PLC
10% Owner
1,785,714 $0 0
(Indirect)
View
2019-07-22
Conversion
2019-07-24
4:01 pm
N/A
N/A
Fulcrum Therapeutics Inc. FULC GLAXOSMITHKLINE PLC
10% Owner
12,500,000 $0 0
(Indirect)
View
2019-10-29
Conversion
2019-10-31
6:27 pm
N/A
N/A
Progyny Inc. PGNY GLAXOSMITHKLINE PLC
10% Owner
9,821,190 $0 0
(Indirect)
View
2019-10-29
Conversion
2019-10-31
6:27 pm
N/A
N/A
Progyny Inc. PGNY GLAXOSMITHKLINE PLC
10% Owner
9,821,190 $0 0
(Indirect)
View
2020-06-22
Sale
2020-06-22
5:29 pm
N/A
N/A
Theravance Biopharma Inc. TBPH GLAXOSMITHKLINE PLC
10% Owner
280,336,000 $29.07 0
(Indirect)
View
2020-07-14
Conversion
2020-07-16
8:13 pm
N/A
N/A
Nkarta Inc. NKTX GLAXOSMITHKLINE PLC
Director
10% Owner
79,090 $0 3,150,732
(Indirect)
View
2020-07-14
Conversion
2020-07-16
8:13 pm
N/A
N/A
Nkarta Inc. NKTX GLAXOSMITHKLINE PLC
Director
10% Owner
525,499 $0 3,150,732
(Indirect)
View
2020-07-14
Conversion
2020-07-16
8:13 pm
N/A
N/A
Nkarta Inc. NKTX GLAXOSMITHKLINE PLC
Director
10% Owner
1,712,810 $0 3,150,732
(Indirect)
View
2020-07-14
Conversion
2020-07-16
8:13 pm
N/A
N/A
Nkarta Inc. NKTX GLAXOSMITHKLINE PLC
Director
10% Owner
292,663 $0 3,150,732
(Indirect)
View
2020-07-14
Conversion
2020-07-16
8:13 pm
N/A
N/A
Nkarta Inc. NKTX GLAXOSMITHKLINE PLC
Director
10% Owner
1,994,348 $0 3,150,732
(Indirect)
View
2020-07-14
Conversion
2020-07-16
8:13 pm
N/A
N/A
Nkarta Inc. NKTX GLAXOSMITHKLINE PLC
Director
10% Owner
6,337,403 $0 3,150,732
(Indirect)
View
2020-07-14
Option Award
2020-07-16
8:13 pm
N/A
2030-07-08
Nkarta Inc. NKTX GLAXOSMITHKLINE PLC
Director
10% Owner
10,700 $18 3,150,732
(Indirect)
View
2020-07-17
Conversion
2020-07-22
4:18 pm
N/A
N/A
Pandion Therapeutics Inc. PAND GLAXOSMITHKLINE PLC
Director
10% Owner
1,538,724 $0 2,248,304
(Indirect)
View
2020-07-17
Conversion
2020-07-22
4:18 pm
N/A
N/A
Pandion Therapeutics Inc. PAND GLAXOSMITHKLINE PLC
Director
10% Owner
348,469 $0 2,248,304
(Indirect)
View
2020-07-17
Conversion
2020-07-22
4:18 pm
N/A
N/A
Pandion Therapeutics Inc. PAND GLAXOSMITHKLINE PLC
Director
10% Owner
7,846,554 $0 2,248,304
(Indirect)
View
2020-07-17
Conversion
2020-07-22
4:18 pm
N/A
N/A
Pandion Therapeutics Inc. PAND GLAXOSMITHKLINE PLC
Director
10% Owner
1,776,980 $0 2,248,304
(Indirect)
View
2020-07-17
Option Award
2020-07-22
4:18 pm
N/A
2030-07-16
Pandion Therapeutics Inc. PAND GLAXOSMITHKLINE PLC
Director
10% Owner
13,997 $18 2,248,304
(Indirect)
View
2020-07-24
Purchase
2020-07-30
8:56 pm
N/A
2024-07-24
GENOCEA BIOSCIENCES Inc GNCA GLAXOSMITHKLINE PLC
10% Owner
1,260,504 $0.125 4,626,389
(Indirect)
View